How is AI revolutionizing drug discovery?
A process that used to take a decade and billions of dollars is being compressed into months.
The answer
AI is transforming pharmaceutical research by predicting molecular structures, identifying drug targets, and simulating clinical outcomes at unprecedented speed. DeepMind's AlphaFold, which predicted the 3D structure of over 200 million proteins by 2022, earned Demis Hassabis the 2024 Nobel Prize in Chemistry. Insilico Medicine's AI-discovered drug ISM001-055 for idiopathic pulmonary fibrosis entered Phase II clinical trials in 2024 - developed in under 30 months compared to the traditional 4-5 year preclinical timeline. By 2025, over 100 AI-discovered molecules had entered clinical trials globally, with companies like Recursion and Isomorphic Labs leading the charge.
Source: Nature
- drug discovery
- healthcare
- alphafold
More from AI & Machine Learning
- What radical question did Alan Turing ask in 1950 that launched the entire field of artificial intelligence?
- Can a machine fool you into thinking it's human - and does that mean it's truly intelligent?
- What happened at a small Dartmouth workshop in 1956 that gave artificial intelligence its name?
- How did a 1958 invention called the Perceptron convince people that machines could learn like brains?
- Could a 1966 chatbot really make people believe they were talking to a therapist?
- What was the first robot that could 'reason' about its own actions?